ANIX
Anixa Biosciences (ANIX)
$96
About Anixa Biosciences (ANIX)
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Details
Daily high
$3.00
Daily low
$2.77
Price at open
$2.80
52 Week High
$5.46
52 Week Low
$2.33
Market cap
98.8M
Dividend yield
0.00%
Volume
763
Avg. volume
224,276
P/E ratio
-8.79
Anixa Biosciences News
Details
Daily high
$3.00
Daily low
$2.77
Price at open
$2.80
52 Week High
$5.46
52 Week Low
$2.33
Market cap
98.8M
Dividend yield
0.00%
Volume
763
Avg. volume
224,276
P/E ratio
-8.79